Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.
Please provide your email address to receive an email when new articles are posted on . Tuberculosis incidence among people aged 50 years or older in the United States is high but declining rapidly ...
Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...
The Clinical Practice Guidelines are the latest from the American Thoracic Society, the Centers for Disease Control and Prevention, European Respiratory Society and Infectious Diseases Society of ...
PARIS (16 November, 2023)—Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing ...
A study led by the University of Cape Town (UCT) has found that most tuberculosis (TB) cases detected among adults living with someone who has TB are silent (without symptoms) at the time of screening ...
NEW YORK (Reuters Health) - Older adults treated for an inactive tuberculosis infection may be at increased risk of suffering liver damage from the medication, a study published Monday suggests.
The final recommendation statement-- a grade B recommendation -- and an updated evidence report and systematic review were published in JAMA, and build on previous guidelines from 2016, which also ...
Epidemiology and Infection, Vol. 146, No. 8 (June 2018), pp. 946-953 (8 pages) The burden of tuberculosis (TB) among adolescents and young adults in endemic settings is poorly characterised. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results